Mukherjee, Debabrata <br/><br/>
Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B).  [electronic resource] 

 -  American heart journal  Dec 2002 
 - 995-1002 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-6744 
<br/><br/><label>Standard No.: </label>10.1067/mhj.2002.126118  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetates--therapeutic use<br/>Acute Disease<br/>Aged<br/>Anticoagulants--therapeutic use<br/>Coronary Disease--drug therapy<br/>Data Interpretation, Statistical<br/>Drug Therapy, Combination<br/>Female<br/>Heparin--therapeutic use<br/>Heparin, Low-Molecular-Weight--therapeutic use<br/>Humans<br/>Male<br/>Middle Aged<br/>Myocardial Revascularization<br/>Platelet Aggregation Inhibitors--therapeutic use<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Randomized Controlled Trials as Topic<br/>Survival Analysis<br/>Tyrosine--analogs & derivatives